Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola

ABSTRACT In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different (∼7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.

[1]  G. Palacios,et al.  Implication of a retrovirus‐like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  V. Volchkov,et al.  Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation , 2006, Journal of Virology.

[3]  H. Klenk,et al.  Homo-Oligomerization of Marburgvirus VP35 Is Essential for Its Function in Replication and Transcription , 2005, Journal of Virology.

[4]  J. Gonzalez,et al.  Fruit bats as reservoirs of Ebola virus , 2005, Nature.

[5]  H. Klenk,et al.  VP24 of Marburg Virus Influences Formation of Infectious Particles , 2005, Journal of Virology.

[6]  A. Sanchez,et al.  Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda. , 2005, Virus research.

[7]  Christian Drosten,et al.  SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis , 2005, PLoS medicine.

[8]  R. Randall,et al.  Pathogenesis of Ebola and Marburg viruses. , 2005 .

[9]  Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[10]  V. Blinov,et al.  The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain , 2005, Archives of Virology.

[11]  A. Peterson,et al.  Potential Mammalian Filovirus Reservoirs , 2004, Emerging infectious diseases.

[12]  S. Nichol,et al.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.

[13]  Tao Zhang,et al.  Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 , 2004, BMC infectious diseases.

[14]  Stuart T. Nichol,et al.  Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome , 2004, Journal of Virology.

[15]  P. Formenty,et al.  Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife , 2004, Science.

[16]  A. Peterson,et al.  Ecologic and Geographic Distribution of Filovirus Disease , 2004, Emerging infectious diseases.

[17]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[18]  C. Roth,et al.  Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo , 2003, Emerging infectious diseases.

[19]  H. Klenk,et al.  Oligomerization of Ebola Virus VP30 Is Essential for Viral Transcription and Can Be Inhibited by a Synthetic Peptide* , 2003, Journal of Biological Chemistry.

[20]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[21]  Philip M. Long,et al.  Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection , 2003, The Lancet.

[22]  J. Modrof,et al.  Ebola Virus Transcription Activator VP30 Is a Zinc-Binding Protein , 2003, Journal of Virology.

[23]  W. P. Duprex,et al.  Modulating the Function of the Measles Virus RNA-Dependent RNA Polymerase by Insertion of Green Fluorescent Protein into the Open Reading Frame , 2002, Journal of Virology.

[24]  H. Klenk,et al.  The Marburg virus surface protein GP is phosphorylated at its ectodomain. , 2002, Virology.

[25]  C. Apetrei,et al.  Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. , 2002, The Journal of general virology.

[26]  C. Möritz,et al.  Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. , 2001, Virology.

[27]  V. Volchkov,et al.  Molecular characterization of guinea pig-adapted variants of Ebola virus. , 2000, Virology.

[28]  H. Feldmann,et al.  Proteolytic processing of Marburg virus glycoprotein. , 2000, Virology.

[29]  P. Jahrling,et al.  Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses , 2000, Laboratory Investigation.

[30]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.

[31]  H. Klenk,et al.  The nucleoprotein of Marburg virus is target for multiple cellular kinases. , 1999, Virology.

[32]  P. Jahrling,et al.  ELISA for the detection of antibodies to Ebola viruses. , 1999, The Journal of infectious diseases.

[33]  A. Sanchez,et al.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[34]  V. Blinov,et al.  Characterization of the L gene and 5' trailer region of Ebola virus. , 1999, The Journal of general virology.

[35]  M. Bray,et al.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. , 1998, The Journal of infectious diseases.

[36]  C. Peters,et al.  Filovirus diseases. , 1999, Current topics in microbiology and immunology.

[37]  H. Feldmann,et al.  Classification, structure, and replication of filoviruses. , 1999, Current topics in microbiology and immunology.

[38]  H. Perry,et al.  Infection control for viral haemorrhagic fevers in the African health care setting. , 1998 .

[39]  A. Sanchez,et al.  Variation in the Glycoprotein and VP35 Genes of Marburg Virus Strains☆ , 1998, Virology.

[40]  J. Mullins,et al.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS , 1997, Journal of virology.

[41]  B. Rima,et al.  Nucleotide sequence analysis of the large (L) genes of phocine distemper virus and canine distemper virus (corrected sequence). , 1997, The Journal of general virology.

[42]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[43]  E. Domingo,et al.  RNA virus mutations and fitness for survival. , 1997, Annual review of microbiology.

[44]  T. Ksiazek,et al.  Experimental inoculation of plants and animals with Ebola virus. , 1996, Emerging infectious diseases.

[45]  P. Jahrling,et al.  Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. , 1996, Archives of virology. Supplementum.

[46]  H. Feldmann,et al.  Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein , 1993, Journal of virology.

[47]  V. Blinov,et al.  The envelope glycoprotein of Ebola virus contains an immunosuppressive‐like domain similar to oncogenic retroviruses , 1992, FEBS letters.

[48]  A. Sanchez,et al.  Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. , 1992, Virus research.

[49]  A. Sanchez,et al.  The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. , 1992, Virology.

[50]  D. Luk,et al.  Nucleotide sequence analysis of the L gene of vesicular stomatitis virus (New Jersey serotype): identification of conserved domains in L proteins of nonsegmented negative-strand RNA viruses. , 1990, Virology.

[51]  P. Argos,et al.  Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. , 1984, Nucleic acids research.

[52]  J. Casals,et al.  Marburg Virus Disease , 1972, The Yale Journal of Biology and Medicine.

[53]  G. Martini Marburg Virus Disease. Clinical Syndrome , 1971 .

[54]  C. Dolea,et al.  World Health Organization , 1949, International Organization.